4-Feb-2025
SA Asks: What's the most attractive weight-loss stock right now?
Seeking Alpha News (Mon, 3-Feb 12:30 PM ET)
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market
Business Wire (Fri, 24-Jan 9:30 AM ET)
Business Wire (Thu, 23-Jan 3:48 PM ET)
Business Wire (Tue, 21-Jan 8:30 AM ET)
Business Wire (Tue, 14-Jan 9:18 AM ET)
Allurion Announces Positive Topline Results From AUDACITY Trial
Business Wire (Wed, 8-Jan 8:00 AM ET)
Allurion Technologies, Inc. Announces Reverse Stock Split
Business Wire (Tue, 24-Dec 7:00 AM ET)
Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance
Business Wire (Mon, 2-Dec 8:00 AM ET)
Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program
Business Wire (Mon, 25-Nov 8:00 AM ET)
Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update
Business Wire (Wed, 13-Nov 8:00 AM ET)
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Allurion Technologies trades on the NYSE stock market under the symbol ALUR.
As of February 4, 2025, ALUR stock price declined to $6.39 with 281,736 million shares trading.
ALUR has a beta of 3.97, meaning it tends to be more sensitive to market movements. ALUR has a correlation of 0.06 to the broad based SPY ETF.
ALUR has a market cap of $30.63 million. This is considered a Sub-Micro Cap stock.
Last quarter Allurion Technologies reported $5 million in Revenue and -$3.50 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $1.00.
The top ETF exchange traded funds that ALUR belongs to (by Net Assets): VTI, VXF, IWC.
ALUR has underperformed the market in the last year with a return of -91.3%, while the SPY ETF gained +23.2%. In the last 3 month period, ALUR fell short of the market, returning -63.9%, while SPY returned +5.7%. However, in the most recent 2 weeks ALUR has outperformed the stock market by returning +118.1%, while SPY returned +0.7%.
ALUR support price is $5.38 and resistance is $7.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALUR shares will trade within this expected range on the day.